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Background:We assessed the feasibility and results of active case detection (ACD) of visceral leishmaniasis (VL),
post kala-azar dermal leishmaniasis (PKDL) and other febrile diseases as well as of bednet impregnation for
vector control.
Methods: Fever camps were organized and analyzed in twelve VL endemic villages in Bangladesh, India, and
Nepal. VL, PKDL, tuberculosis, malaria and leprosy were screened among the febrile patients attending the
camps, and existing bednets were impregnated with a slow release insecticide.
Results: Among the camp attendees one new VL case and two PKDL cases were detected in Bangladesh and one
VL case in Nepal. Among suspected tuberculosis cases two were positive in India but none in the other countries.
In India, two leprosy cases were found. No malaria cases were detected. Bednet impregnation coverage during
fever camps was more than 80% in the three countries. Bednet impregnation led to a reduction of sandfly dens-
ities after 2 weeks by 86% and 32%, and after 4 weeks by 95% and 12% in India and Nepal respectively. The
additional costs for the control programmes seem to be reasonable.
Conclusion: It is feasible to combine ACD camps for VL and PKDL along with other febrile diseases, and vector
control with bednet impregnation.
Keywords: Active case detection, Bednet impregnation, Febrile cases, Post kala-azar dermal leishmaniasis, Visceral leishmaniasis,
Sandfly control
Introduction
Visceral leishmaniasis (VL) is an important public health problem
in India, Bangladesh and Nepal. The regional VL elimination pro-
gram with the target to reduce the annual incidence of VL below
one case per 10 000 inhabitants by 2015 was launched in 2005
after the signing of a memorandum of understanding among
Bangladesh, India and Nepal. The multi-national VL elimination
programme aims at the interruption of disease transmission
through the control of the vector Phlebotomus argentipes–an
indoor night biting exclusively anthropophilic sandfly with high
densities between March and August when temperature and
humidity are high–and the early identification of disease through
effective disease surveillance and access to health care for VL
treatment with particular attention to the poor and marginalized
communities of VL endemic foci.1,2
Detection of all clinical types of VL (active clinical, subclinical
and asymptomatic) and their management is very pertinent in
order to bring down the parasite load in the community.3 The
identification of disease foci is essential as the VL cases are
found in clusters in the endemic areas.4
# The Author 2015. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the
original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
O
R
IG
IN
A
L
A
R
TI
C
LE
Trans R Soc Trop Med Hyg 2015; 109: 408–415
doi:10.1093/trstmh/trv031
408
During recent years a continuous decrease of VL cases has
been observed in the three countries, coming close to the elimin-
ation goal. Active case detection (ACD) in the endemic areas,
using a case definition according to national guidelines in the
three countries (i.e., fever for more than 2 weeks, spleen enlarge-
ment and positive rapid diagnostic test rK39 [Gilead Sciences,
Alberta, Canada]), is essential for further reducing and finally
interrupting parasite transmission by detecting and treating new
cases at an early stage.5 During the late stage of the attack phase
of elimination, the priority must be to effectively implement exist-
ing interventions at the community level through ACD in endemic
villages.6 Lack of active disease surveillance results also in the
under-reporting of VL burden7 which is particularly detrimental
to the elimination initiative. A multi-center study conducted in
Bangladesh, India and Nepal found that the proportion of VL
cases detected through ACD was high compared to cases
reported through routine surveillance.5 The analysis of the effect-
iveness of ACD for new VL cases using house to house screening in
Bangladesh and India and neighborhood screening around index
cases in Nepal revealed that the percent increase of new VL cases
through ACD compared to passive case detection (PCD) was 6.7–
17.1% in India,38.8% in Nepal and 60% in Bangladesh.8 However,
the number of new VL and post kala-azar dermal leishmaniasis
(PKDL) cases was limited in areas of lower endemicity, therefore
the efficiency (i.e., cost in relation to the results) of fever camps
could be improved by screening for other fever diseases (tubercu-
losis and malaria) or skin afflictions (leprosy); additionally vector
control through insecticide treated bednets would enhance the
impact of the combined fever camps.9,10
We organized mobile one-day ‘fever camps’ (no over-night
stay; the term ‘camp’ adopted from national programme) in vil-
lages to screen and diagnose VL, PKDL, leprosy,malaria and tuber-
culosis among residents with chronic fever (for more than 2
weeks) or skin disease and to treat the existing bednets, which
were very common in the area, with pyrethroid insecticides for
vector control. The mobile teams conducting these ‘combined
fever camps’ included medical officers, laboratory technicians
from the district/sub-district health office and community health
workers. The case detection of VL and other fever diseases and
vector control activities were combined in order tomake transmis-
sion prevention complete (early case detection and reduction of
vector density) and to increase the efficiency of these camps
(reduced cost per fever case diagnosed).The main objective of
this study was to assess the feasibility, costs and results of a
combination of active VL and PKDL case detection (including
other fever diseases) and transmission reduction through vector
control (bednet impregnation with slow release insecticide
KOTAB 123, Bayer, Lyon, France) using the combined camp
approach in Bangladesh, India and Nepal.
Materials and methods
Study districts and selected villages
VL incidence has now decreased to low levels in the three countries;
districts with VL endemicity levels slightly above (Bangladesh, India)
or below (Nepal) the elimination target of 1 case per 10 000 inhabi-
tants; Table 1) were selected for the study in co-ordination with
the national programmes: Mymensingh (Trishal sub-district) in
Bangladesh, Vaishali in India and Saptari in Nepal. The study cov-
ered four villages in each of the three countries including on average
in each village 2390 inhabitants in Bangladesh, 8397 in India and
1920 in Nepal.
Study design
A cross-sectional evaluation (exploratory proof of concept) study
was conducted from June to August 2013 to determine the feasi-
bility and constraints of combined fever camps with VL and PKDL
ACD (including the detection of other febrile diseases) and vector
management (including the analysis of the reduction of vector
densities). Both qualitative and quantitative research methods
were used.
Intervention activities (combined fever camps)
The research team together with the national and district level
health officers first developed a plan for combined fever camps
in the target areas. Then these activities were conducted in the
villages together with the control staff of the national pro-
grammes. Discussion and orientation meetings were held with
district health officers.
Pre-camp activities
Date, time and place of each camp, in particular health post, sub
health post or Primary Health Care Centres, were defined.
Community health volunteers and health workers were identified
Table 1. Background characteristics of the study area
Characteristics Bangladesh India Nepal
Study district/sub-district Trishal (Mymensingh) Vaishali Saptari
Number of VL cases in 2012 in the study districta 270 2076 47
Number of villages selected 4 4 4
Number of VL cases in the selected villages in one year 4 23 18
Incidence of VL per 10 000 population in 2012/2013 in district/sub-district 6.4 (270/424 243) 7.6 (2076/2 718 421) 0.7 (47/657 971)
a District and sub-district health/public health offices.
VL: Visceral leishmaniasis.
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by the mobile camp teams from the district and sub-district
assisted by the research team and trained to disseminate the
message of the forthcoming fever camp, its purpose and who
was supposed to attend the camp. Only people with fever and
skin lesions were invited to attend the camp. The untreated bed-
nets in the community were expected to be washed before the
camp day and people were informed to bring those bednets for
impregnation with KOTAB 123. The health workers disseminated
the message 2–3 days (in Bangladesh 7 days) ahead of the
camp day by house to house visits and meetings with village
leaders.
Camp activities
A district mobile camp team consisting of one doctor, one health
assistant and one laboratory technician visited the defined com-
munities in each area to conduct the one-day camps. The camps
in Nepal moved from community to community covering four
communities in four days; in Bangladesh and India the teams
returned in the evenings to the base (small hospital or Primary
Health Care Centre). At the camp (usually a small school or com-
munity building), patients with fever were registered at the regis-
tration desk. Registered patients were examined and screened by
the physician who decided on the further procedure. The labora-
tory technician performed rapid diagnosis for VL (in case of fever
and spleen enlargement), PKDL andmalaria at the camp site. The
physician filled the referral forms for suspected tuberculosis and
leprosy cases as well as for VL and PKDL cases (see below). The
formats developed by the research team were used for registra-
tion, clinical examination by physicians and rapid diagnosis by
laboratory technicians. Copies of all forms (including the filled
referral forms collected from local hospitals) were kept at a central
office by the research team and analysed by the data manager in
each of the three country teams. The patients with VL (with
chronic fever, spleen enlargement and positive in the rK39 test)
diagnosed in the campwere referred to the nearest district or sub-
district hospital for further diagnosis and treatment. Prior to
organizing the camps, district and sub-district hospitals were
informed by the camp teams about their role for the confirmatory
diagnosis and treatment of referred patients from the camps.
Patients with VL, after confirmatory diagnosis at district or sub-
district hospitals, were reimbursed for travel and food costs and
daily wages lost as per national program guidelines and norms.
Patients suspected of having PKDL—a potentially communicable
form of post-treatment leishmanisasis—were diagnosed by
examining skin lesions and rK39 test. Patients with skin lesions
and a positive rK39 test were referred and re-confirmed as
PKDL positive cases in the district or sub-district hospital.
Patients with skin lesions with a negative rK39 test result
were clinically examined for leprosy and referred to the next
hospital or primary health care centre for further examination.
Rapid diagnostic tests (SD-Bioline, Standard Diagnostics Inc.,
Yongin-si, Gyeonggi-do, Republic of Korea) for malaria were
used in the few villages of Nepal where malaria is prevalent.
The patients suspected of having malaria, leprosy and tubercu-
losis were referred to the district hospital for confirmatory
diagnosis with sputum smear (tuberculosis), blood smear
microscopy (malaria) and skin examination (leprosy) and for
treatment if confirmed. The referral forms and hospital reports
were later analyzed by the research team.
Bednet impregnation in combined fever camps
During the camps and parallel to the clinical evaluation of fever
patients vector control activities were conducted by impregnating
the pre-existing bednets (note that the mesh size of non-
impregnated nets allows sandflies to enter the net) with a slow
release insecticide. Bednets were brought to the camp place by
household members. They were impregnated by previously
trained village health workers, under the supervision of the health
assistant, with KOTAB 123 slow release insecticide, following the
method described by Shreck and Self.11 The active ingredient of
KOTAB 123 is WHO specified deltamethrin with favourable
bio-efficacy and a high safety level.12 The impregnation of ordin-
ary nets –which had a high household coverage in the study
areas – with KOTAB123 transformed these into insecticide treated
nets with long term protection. In our previous study the efficacy
remained for at least 18 months, even after 25 washes.9 After
bednet impregnation, community people were told to dry the
bednets in shadow and keep folded during the day. No additional
KOTAB 123 were provided to the community people for future use
(see Discussion).
Research activities
Qualitative and quantitative research
A formal survey was conducted with the 16 staff members
involved in the camp activities of the three countries, asking
questions about the need for doing such camps, their positive
and negative experiences and suggestions for improvements.
Additionally, observations using an observation checklist were
conducted in the camps and community meetings after the
camps for getting information on the peoples’ perception of the
intervention. Socio-demographic information and bednet use by
the villagers was collected by structured interviews (392 in
Bangladesh, 2048 in India and 300 in Nepal) and observation in
all study households.
Determination of effectiveness of bednet impregnation
Sandflies were collected using CDC light traps hung in the bed-
rooms on two consecutive nights from 20 randomly selected
households in the eight study villages and two matched control
villages in India and Nepal (no measurement in Bangladesh due
to resource constraints) at 2 weeks before, 4 weeks and 24 weeks
after the impregnation of bednets and in control villages at the
same time points. The procedure of sandfly collection, preserva-
tion and identification was followed as stated in the monitoring
and evaluation toolkit.13
Determination of resource needs and feasibility of combined
fever camps
‘Feasibility’ as a combined variable was defined as the viability of
conducting one-day fever campswith the given financial,material
and human resources. To this end a series of sub-studies was
conducted:
1. At district hospitals, district public health offices and primary
health care centres, observations were made to assure the
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availability of the storage and distribution system of rK39 and
VL drugs. In addition, equipment and supplies needed for the
combined approach were identified and documented.
2. The costs of each item (personnel cost for case detection and
bednet impregnation, cost of diagnostics and logistics, supplies
and travel cost) using the ingredients method as well as staff
time were recorded to enable the estimation of direct costs for
the fever camps (NB: only the ‘additional costs’ for the national
control program have been assessed because this is what the
program officer considers when deciding about the adoption of
a new strategy).The above mentioned costs of different
resource elements were estimated (using allocation factors
such as percentage of time spent by staff or vehicle used);
they were then added up to get the total costs of a fever
camp. Then average or unit cost per case detected (VL, PKDL,
leprosy and tuberculosis) and cost per bednet impregnated
and per household protected were calculated.
3. The completion of the work within 6 to 7 working hours per
camp was documented.
4. At the end of the study period all field staff involved were inter-
viewed with a standardized questionnaire soliciting opinions
and experiences about ACD and vector management. It was
originally intended to also interview the patients attending
the camp, but it became clear that this would have interfered
with the routine camp activities.
Data management and analysis
Data were entered using EpiInfo version 3.3.5(CDC, Atlanta, GA,
USA). Data were checked and cleaned before analysis. Descriptive
statisticswere explored. The percent changes (PC) of sandflycounts
attributed to intervention compared to the control areaswas calcu-
lated as:
PC = (EF/mean (A)) ∗ 100
Where, EF (effect of intervention)¼ [median(B) – median (A)] –
[median (D)-median (C)]; and A¼baseline median sandfly count
for the intervention area; B¼post-intervention sandfly count for
the intervention area; C¼baseline sandfly count for the control
area; D¼post-intervention sandfly count for the control area.
Effect is negative or positive if sandfly density is decreased or
increased after intervention and the effect should be zero if sandfly
density is same as at baseline. Difference of sandfly count between
pre and post intervention measurement for both intervention and
control areas were assessed. Comparison of median difference in
sandfly density between intervention and control areas was done
using Mann-Whitney U test and p-value was reported. All calcula-
tions were performed by SPSS 13 (IBM, Armonk, NY, USA) and STATA
10 (Stata Corp LP, College Station, TX, USA).
Ethical considerations
The study received written consent from the participants. The diag-
nostic procedure followed national guidelines and no alternative
drugs were tested. The study received ethical clearance by Ethical
Review Committee, World Health Organization (ERC-WHO) and by
institutional review boards of each country.
Results
Background information
The annual VL incidence per 10 000 population in 2012 was,
according to official statistics, 6.4 in Trishal sub-district of
Bangladesh, 7.6 in Vaishali district of India, and 0.7 in Saptari dis-
trict of Nepal (Table 1).
Active case detection
During pre-camp activities, community people with fever or skin
lesions were invited to attend the camps. A total of 100 people
in Bangladesh, 220 in India and 85 in Nepal attended the four
combined fever camps in each country. Among them, patients
with fever for more than 2weeks numbered 23, 42 and 37 in
Bangladesh, India and Nepal respectively. The spleen examin-
ation showed a slight to marked spleen enlargement in one
case in Bangladesh, one in Nepal and none in India. The rK39
test was positive in three patients in Bangladesh, five in India,
and one in Nepal. All patients positive by rK39 in India were past
VL cases. The patients positive by rK39 in Bangladesh and Nepal
were referred to district or sub-district hospitals for final diagnosis.
Only one patient was positive for VL out of three referred to hos-
pital in Bangladesh and one patient confirmed as having VL was
referred to hospital in Nepal. In Bangladesh, two patients were
positive for PKDL according to the final confirmatory diagnosis
at district or sub-district hospitals (Table 2).
In Nepal, 33 individuals suspected of having malaria were
tested with rapid diagnostic tests (SD-Bioline) but none were posi-
tive. Among two patients suspected and tested for tuberculosis in
Bangladesh, five in India, and 34 in Nepal, two in India were spu-
tum smear positive. Similarly, among four patients suspected and
tested for leprosy, two were clinically diagnosed as having leprosy
in India (Table 3). The patients with fever who were negative of
abovementioned tests were referred to district or sub-district hos-
pitals but they could not be followed due to resource constraints.
Bednet impregnation: coverage and effect on the vector
population
In the fever camps, existing bednets of the study villages were
impregnated with KOTAB 123. From the community survey con-
ducted before organizing the combined camp, it was found that
households having untreated bednets were 97.2% (381/392) in
Bangladesh, 59.3% (1214/2048) in India, and 89.3% (268/300)
in Nepal. The median number of bednets per household was
two. Regular use of bednets by all family members of the house-
hold was 58.7% (230/392) in Bangladesh, 23.2% (281/2048) in
India and 67.7% (203/300) in Nepal. The bednet impregnation
rate was 82.1% (653/795) in Bangladesh, 81.5% (1680/2060) in
India, and 99.8% (536/537) in Nepal (Table 4).
Besides the camp activities, the research team measured the
sandfly density at baseline, 2 and 4 weeks after bednet impregna-
tion in intervention and control villages in India and Nepal (no
measurement in Bangladesh due to staff shortage). The reduction
in sandfly density after 2 weeks of bednet impregnation was
86.5% and 32.6% in India and Nepal respectively as compared
to baseline: the reduction after 4 weeks was 94.6% and 12.5%
in India and Nepal respectively. The reduction was significant in
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India and non-significant in Nepal for both measurements
(Table 5).
Feasibility and acceptability of the combined camp
approach
The rK39 test kits, drugs for the treatment of VL, and other sup-
plies for VL case management were available in district and sub-
district health facilities of the three countries. Physicians of district
and sub-district hospitals of the three countries and primary
health care centres of Nepal and India had previously been
trained for VL diagnosis and treatment. Public health authorities
at district and sub-district level of the three countries were
found maintaining up to date information of VL cases including
linelisting of the cases and timely reporting to the central level.
All the activities in the camps including registration, record keep-
ing and case referral were done properly and within the given
working time according to observation and document analysis
by the research teams.
All 16 health workers of the three countries involved in the
combined fever camps expressed in the interviews their positive
experiences and feelings. Typical examples were: We like the
fever camps and want to continue the ACD camps including bednet
dipping (physician involved in camp activities in Bangladesh).
People in the community were also satisfied with their fever diag-
noses and bednet impregnation: I would have bought some new
bednets for dipping if I had known the advantages of such activity
before (community people attending camp in Nepal).
Government health workers who actively participated in the
camps particularly underlined the importance of ACD and vector
control during the maintenance phase of VL elimination. It was,
however, suggested to further improve the pre-camp activities
so that all fever patients would attend the camps.
Cost analysis
Cost per case detected (VL, PKDL, leprosy or tuberculosis) was
US$219, 232.5 and 500.6 for Bangladesh, India and Nepal respect-
ively (Table 6). When taking only VL or PKDL cases, the cost per case
detected was US$219.0 in Bangladesh, and US$500.6 in Nepal.
Regarding cost per combined camp, the total cost was US$164.25
in Bangladesh, US$232.5 in India and US$125.15in Nepal
(Table 6). However, when including only the ‘additional costs’
which health services would have to bear, these would be much
lower as they include only travel costs to the endemic villages and
daily allowance plus some capacity building activities, but not
salaries.
Discussion
ACD and early treatment has been recommended for long lasting
communicable diseases in order to shorten the transmission per-
iod of the infective agent and to reduce human suffering. As an
Table 3. Detection of malaria, tuberculosis and leprosy in four
camp villages per country
Characteristics Bangladesh India Nepal
Number of cases suspected and
tested for malaria
0 0 33
Number of malaria positive cases 0 0 0
Number of cases suspected and
tested for tuberculosis
2 5 34
Number of tuberculosis positive cases 0 2 0
Number of cases suspected and
tested for leprosy
0 4 0
Number of leprosy positive cases 0 2 0
Table 2. Detection of visceral leishmaniasis (VL) and post kala-azar dermal leishmaniasis (PKDL) cases in four camp villages per country
Characteristics Bangladesh India Nepal
Number of camp attendees 100 220 85
Number of fever cases screened in the campa 25 42 53
Cases with fever more than 2 weeks 23 42 37
Fever cases with enlarged spleen 1 0 1
Cases with past VL history 3 5 1
rK39 test doneb 3 42 24
rK39 test positive (including past VL cases) 3 5 past VL cases 1
Final diagnosis for VL (fever+ enlarged spleen+ rK39 positive) 1 0 1
Skin lesion like PKDL 2 0 0
Patient referred for VL/PKDL confirmatory diagnosis and treatmentc 3 0 1
rK39: rapid test for VL and PKDL.
a The remainder had either skin lesions or recent feverish conditions (e.g. common cold) or diseases without fever (e.g. chronic diarrhea).
b In India and Nepal rK39 test was done on most or all cases with chronic fever, disregarding the spleen examination.
c Includes in Bangladesh and Nepal patients with skin lesions unlike PKDL.
M. R. Banjara et al.
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example: the lag time from onset of VL symptoms to treatment
was 104 days in India and 58 days in Nepal14; this would be con-
siderably reduced by ACD andwill be an indicator in further studies
(see Conclusions). Different ACD methods have been tested
against the gold standard of house-to-house screening; both
the camp approach (detecting new cases in fever camps) and
the incentive approach (detecting new cases through village
health workers) were most promising due to relatively low costs
and high yields of new cases.15,16 One question which came up
repeatedly in the context of ACD studies was what to do with
the many fever patients who were not suffering from VL.
Therefore, in the present studywe extended ACD to other diseases
where rapid diagnostic tests are available (such as malaria and to
a less extent tuberculosis) or skin diseases similar to PKDL, in
the case of our study region leprosy. Other diseases diagnosed
by the camp doctors such as common cold or chronic diarrhea
were not systematically registered. Due to resource constraints
the patients with fever negative for our target diseases could
not be followed; this will more systematically be done in the forth-
coming extended study (see Conclusions). Regarding vector
control, it had been shown in rural Bangladesh that a bednet
impregnation programme with involvement of local communities
can be cost-effective,9,10 therefore combining different
approacheswithout overburdening health workers and communi-
ties. Particularly, the national control programme in Bangladesh is
considering the replacement of the expensive indoor residual
spraying programme with impregnating existing bednets
(national programme manager, personal communication).
Regarding the ‘feasibility of combined fever camps, our study
showed that it is technically feasible to conduct with the existing
resources combined fever camps for detecting VL, PKDL, tubercu-
losis, leprosy andmalaria, and to conduct at the same time vector
control operations. Only the costs for the health services need fur-
ther consideration.When estimating only the ‘additional costs’ for
the Ministry of Health (mainly travel costs and per diem for health
workers but not the costs for consumables–forms and diagnostic
tests–which are covered by the routine budget) the costs per
camp go down and they may be further reduced if combined
camps are part of routine operations where every team member
knows his or her role and responsibility and health staff can be
partly replaced by community health workers. Indirect benefits
of the camp activities were not included in the equation although
they are probably considerable. To these belong the treatment
of other diseases by the doctor during the camp, the reduced
indirect costs for patients arising from early detection of the dis-
ease and avoiding the long pathways to diagnosis and treat-
ment, and from averting parasite transmission through early
diagnosis and vector control. Furthermore, when moving towards
VL elimination, elevated cost for identifying the last few cases in
order to interrupt the transmission will be accepted by health
Table 5. Median sandfly density per Centers for Disease Control (CDC) light trap per night before and after 2 and 4 weeks of bednet impregnation
Timeline Median (IQR) sandfly density (per CDC light trap per night)
India Nepal
Intervention Control Intervention Control
Before intervention 3.5 (3.0–4.38) 3 (2.5–4) 8.25 (1.50–20.75) 1.50 (1.13–10.88)
After 2 weeks of intervention 0.0a (0.0–0.5) 3.0 (2.5–3.5) 10.0 (4.50–15.13) 7.50 (3.63–8.00)
After 4 weeks of intervention 0.5a (0.13–0.88) 3.5 (3.0–4.0) 4.75 (2.63–17.75) 9.50 (4.0–15.75)
a Significant reduction (p,0.05); Mann-Whitney U test.
Table 4. Bednet related information in four camp villages per country
Characteristics Bangladesh India Nepal
Number of HHs in study villages 392 2048 300
Median number of living rooms per HH 2 2 2
Number of HHs with bednets, n (%) 381 (97.2) 1214 (59.3) 268 (89.3)
Median number of bednets in each HH 2 2 2
Bednet material 98.2% nylon 99.6% nylon 89.0% nylon
Median number of family members in the house 5 5 6
HHs with regular use of bednets by all family members, n (%) 230 (58.7) 281 (23.2) 203 (67.7)
Total number of bednets in the study villages 795 2060 537
Total number and proportions of bednets impregnated in the camps, n (%) 653 (82.1) 1680 (81.5) 536 (99.8)
HH: household.
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authorities as expressed by national program managers in an
evaluation workshop of the here presented research. These strat-
egies could be sustainable since the national programmes of
these three countries have intensified their effort in ACD of VL
and PKDL and vector control. Involvement of local health facility
and organizing camps in the local health facility and out-reach
clinics would cover the target population.
The bednet impregnation coverage was high (almost 100% in
Nepal and approximately 82% in India and Bangladesh) and the
reduction of the vector population was significant in India but not
statistically significant in Nepal although a recent efficacy trial in
Nepal with the same slow release insecticide as used in our study
showed a significant reduction of VLvector densities (ML Das, per-
sonal communication; publication in preparation). This may be
because in Nepal both intervention and control villages were cov-
ered additionally by indoor residual spraying with pyrethroid
insecticides so that the impregnation of bednets did not provide
an additional significant benefit. Informal conversations during
the camps showed that the population was satisfied; they repeat-
edly mentioned that not only a small segment of the community
(patients with fever) was attended but the whole population felt
the benefits from the camps. From the provider point of view, the
participating health staff was satisfied with the combined camps
and recommended the strategy for general use in the national
programmes. A workload assessment had previously shown
that in most primary health care units there would be sufficient
staff time available to carry out combined camps.17
National programme managers–who are involved in the
design and analysis of this research porogramme–are willing to
spend more resources on combined fever camps if the benefits
of early detection of public health relevant diseases are obvious;
particularly when, with the decline of VL cases, the largely
unchanged burden of tuberculosis and the constant appearance
of new leprosy cases justify the intervention and when in the
geographical malaria-VL overlap areas new malaria cases can
be detected through the camp approach. This will be further
tested in a more extended study which will also include the
detection of other infectious diseases.
The main limitation of this study was the small sample size;
however, we could show in this exploratory study that it is feasible
to conduct combined fever camps within the context of national
control programs and that the potentials for detecting several
fever diseases and organizing at the same time vector control
are promising for themaintenance phase of the VL elimination ini-
tiative. Also the inclusion of only a reduced number of diagnostic
tests can be overcome by doing extended testing of candidate
pathogens during the fever camps. Regarding the bednet impreg-
nation program, we have learned that the advanced promotion at
community level is needed for achieving a high coverage of
insecticide treated nets.
Conclusions
With the decrease of VL/PKDL cases in the context of the elimin-
ation initiative it is necessary to use a cost-effective case
detection tool which has been explored in this study. This proof-
of-principle study provides the first piece of evidence that case
detection of various diseases combined with vector control inter-
ventions for VL elimination during the consolidation andmainten-
ance phase is a promising approach for being integrated into the
national control programmes. Further analysis of the strategy
presented here of combined fever camps (ACD of an extended
number of fever diseases and at the same time organization of
vector control operations) in larger settings is planned for the
near future.
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Table 6. Cost of active case detection and bednet impregnation in
combined camps
Particulars Bangladesh India Nepal
No. of VL or PKDL case detected 3 0 1
Total number of bednets
impregnated
653 1680 536
Travel cost 78 132 100.80
Daily allowance 545 621 365.9
Cost of rK39 test kit for VL or PKDL 8 42 24.00
Cost of KOTAB 123a NA NA NA
Logistics for camp (record keeping,
referral forms)
26 135 9.9
Total cost of four camps 657 930 500.6
Cost per case (VL, PKDL, TB, leprosy)
detected
219.0 232.5 500.6
Cost per bednet impregnated 0.67 0.55 0.93
Cost per combined camp 164.25 232.5 125.15
NA: not applicable; PKDL: post kala-azar dermal leishmaniasis; rK39:
rapid test for VL and PKDL; VL: visceral leishmaniasis.
All costs are given in US$.
a KOTAB123 (slow release insecticide for bednet impregnation)
provided by the programme.
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